Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Goodwin Advises Boston Scientific in its Acquisition of Elutia Inc.’s BioEnvelope Business

main

announcements-practices-ma-goodwin-advises-boston-scientific-in-acquisition-of-elutia

Goodwin advises Boston Scientific on $88M acquisition of Elutia’s BioEnvelope business, expanding its MedTech portfolio.

Goodwin Advises Boston Scientific in its Acquisition of Elutia Inc.’s BioEnvelope Business

Related Content

How to Secure and Retain Top Talent in Asset Purchases

SEC’s Division of Corporation Finance Provides Post-Shutdown Guidance

California Air Resources Board Posts Draft Scope 1 and 2 GHG Reporting Template

SEC Chairman Vows to Make IPOs Great Again

M&A Activity Continues to Escalate in the Global Hotel Operator Sector

OCC Issues Guidance and Proposed Rules to Reduce Regulatory Burdens on Depository Institutions

SEC Guidance on Operations During the U.S. Federal Government Shutdown

Goodwin Antitrust & Regulatory Shorts: 10 Insights for Understanding and Managing Risk in Below-Threshold M&A

Goodwin Advises Lumine Group on Agreement to Acquire Synchronoss Technologies

Goodwin Expands London Technology M&A Team with the Arrival of Emmie Jones

The Wolves Are Howling: Activist Packs Are Complicating Engagement (Agenda)

Goodwin Advises Avadel Pharmaceuticals on Increased Offer from Alkermes

Goodwin Advises Centerview Partners on Semrush’s $1.9 Billion Acquisition by Adobe

Goodwin Advises SixPeaks Bio on Acquisition by AstraZeneca for Up to $300 Million

Vidi Capital Acquires the group CIL11

Bumble Enters into Agreement to Terminate Tax Receivable Agreement for $186 Million

Medtech

Mergers & Acquisitions